Neocis, specializing in robot-assisted dental implant surgery, has raised $20 million in additional funding. This financial boost, secured despite the challenging macroeconomic conditions of 2023, was led by Mirae Asset Capital/Mirae Asset Venture Investment, affiliated with the Mirae Asset Financial Group, and NVentures, NVIDIA’s venture capital arm.
Based in Miami, Neocis is developing Yomi, a robotic surgical system in dentistry cleared by the U.S. Food and Drug Administration (FDA). The Yomi platform has achieved a total of 16 FDA 510(k) clearances. It aids clinicians throughout the implant placement process by providing streamlined digital planning and haptic guidance of surgical instruments, enhancing precision and efficiency. As of now, over 40,000 implants have been placed using this robotic assistance, with a dental implant being placed approximately every six minutes, based on Neocis’ data.
The recent funding is expected to propel the company’s growth in the dental robotics market. Neocis plans to utilize these funds across various business initiatives, including product development, sales enablement, and clinical education. Moreover, the company has expanded its operations by moving into a larger headquarters in Miami’s Wynwood neighborhood, which features a state-of-the-art manufacturing facility.
This investment underlines the growing interest and confidence in the field of dental robotics, indicating a positive outlook for innovations that enhance the efficiency and quality of dental procedures. Neocis’ advancements in this area exemplify the potential for robotics and artificial intelligence to transform healthcare practices, particularly in specialized fields like dentistry.
